Numu Capital

Numu Capital is a Saudi-affiliated, Dubai-based fund providing essential early-stage capital to tech startups with high scalability potential, with documented exposure to medical tourism (Doctoorum) among other sectors. Check sizes of $250k to $1M place the firm in the seed range. Healthcare exposure includes care delivery and digital health. The firm is not specifically AI-focused; the lens is general scalable tech in MENA.

The firm’s natural fit is with MENA founders building tech-enabled platforms with credible regional scale potential, including healthcare-specific applications such as medical tourism platforms, telehealth networks, and care delivery infrastructure. The right founder profile is a regionally anchored team with credible local operational experience and a clear path to multi-country scale across GCC and broader MENA markets. Founders building deep biotech, pure US-market software without MENA wedge, or anything requiring extensive patient capital are not the natural target.

Geographically, Dubai is a credible regional hub with strong connectivity to GCC markets and to international capital. Numu’s positioning bridges Saudi and broader GCC ecosystems. For founders building primarily for the Saudi market with cross-GCC ambitions, the firm can be a useful early partner. For founders without GCC ties, the strategic logic is thin.

The right entry path is a warm intro from a portfolio founder, a regional MENA VC, or a senior operator at one of the GCC corporate or family-office investors. The firm reads partner-led decks and responds to clear regional scalability theses. The pitch should lead with the MENA market wedge, evidence of early traction, and a credible follow-on plan that addresses cross-border GCC capital realities.

Caveats. GCC fund structures interact with cross-border venture dynamics in idiosyncratic ways; engage experienced regional counsel. The firm’s healthcare-specific portfolio depth is not as visible publicly as its broader scalable-tech portfolio; reference calls with portfolio founders, including Doctoorum, are advisable. The check size is moderate; for founders raising larger seeds, Numu should be a participant alongside a real lead. For MENA-anchored health-tech founders with credible regional ambitions, Numu Capital is a useful early participant; for founders without GCC ties, dedicated MENA health funds with deeper specialty are better.